Bios Equity Partners II, LP
CIK 0001813313
Director10% Owner
Filings
20
Latest Jun 30, 2025
Issuers covered
5
Showing
20 of 20
Page 1
Track record
73 of 73 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 73 | 22% | -14.9% | -9.5% | +37.6% | -97.7% |
| 90 days | 73 | 22% | -22.0% | -22.6% | +63.1% | -63.1% |
| 180 days | 73 | 30% | -8.9% | -14.2% | +74.7% | -74.7% |
| 365 days | 52 | 56% | +0.5% | +6.7% | +97.1% | -97.1% |
Issuers
Companies where Bios Equity Partners II, LP has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| LTRN | Lantern Pharma Inc. | 7 | Jun 13, 2025 |
| CGTX | Cognition Therapeutics Inc | 5 | Jun 20, 2025 |
| ACTU | Actuate Therapeutics, Inc. | 4 | Jun 30, 2025 |
| INAB | In8bio, Inc. | 3 | May 7, 2025 |
| AZTR | Azitra Inc | 1 | Jun 23, 2023 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|